Año: 2017
Journal Impact Factor (JIF): 4.1160
| Categoría | Edición | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|---|
| INFECTIOUS DISEASES | SCIE | 20/88 | Q1 | T1 | D3 |
| IMMUNOLOGY | SCIE | 49/155 | Q2 | T1 | D4 |
Año: 2017
Journal Citation Indicator (JCI): 1,110
| Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
|---|---|---|---|---|---|
| IMMUNOLOGY | 43/173 | Q1 | T1 | D3 | 75,43 |
| INFECTIOUS DISEASES | 25/111 | Q1 | T1 | D3 | 77,93 |
Año:
2017
CiteScore:
6,900
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Infectious Diseases | 38/274 | Q1 | T1 | D2 |
| Pharmacology (medical) | 27/238 | Q1 | T1 | D2 |
SJR año:
2017
Factor de Impacto:
2,368
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Infectious Diseases | 20/283 | Q1 | T1 | D1 |
| Infectious Diseases | 20/307 | Q1 | T1 | D1 |
| Pharmacology (medical) | 9/254 | Q1 | T1 | D1 |
| Pharmacology (medical) | 9/279 | Q1 | T1 | D1 |
| Agencia | Código de Proyecto |
|---|---|
| Canadian Foundation for AIDS Research grant | - |
| Canadian Institutes of Health Research (CIHR) | TCO-125269 |
| Canadian Institutes of Health Research New Investigator Award | MSH-141971 |
| Genome BC | - |
| Genome Canada | - |
| Gilead Sciences | - |
| Instituto de Salud Carlos III | CD14/00320 |
| Janssen | - |
| Merck | - |
| NATIONAL INSTITUTE ON DRUG ABUSE | U01DA038886 |
| US National Institutes of Health | U01DA038886 |
| ViiV Healthcare | - |
| # | Autor |
|---|---|
| 1 | |
| 2 | Ajaykumar, A |
| 3 | Gadawski, I |
| 4 | Munoz-Fernandez, MA |
| 5 | Hayashi, K |
| 6 | Harrigan, PR |
| 7 | Cote, HCF |